Role of Fibroblast Thy-1 in Pulmonary Fibrosis
Role of Fibroblast Thy-1 in Pulmonary Fibrosis
批准号:
6624221
负责人:
James S. Hagood
金额:
$26.12万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-05-22 至 2006-03-30
关键词:
biological signal transduction biomarker bone marrow transplantation cell growth regulation cell proliferation fibroblasts fibrogenesis gene targeting glycoproteins glycosylphosphatidylinositols growth factor human tissue idiopathic pulmonary fibrosis interleukin 1 laboratory mouse pulmonary fibrosis /granuloma tissue /cell culture
中文摘要
肺的纤维性疤痕会导致严重的残疾,常常导致死亡。持续性成纤维细胞增殖对治疗具有抵抗力,预示着预后不良。Thy-1糖蛋白的表达可能是影响成纤维细胞纤维化潜能的关键因素。缺乏Thy-1(Thy-1-)的成纤维细胞具有纤维化病变成纤维细胞的许多表型特征,并且对纤维化生长因子具有增强的增殖反应,这可能导致它们在纤维化病变中积聚或持续存在。这些研究基于这样的假设,即Thy-1的表达改变了细胞内信号通路的激活和细胞对纤维化介质的反应,从而调节成纤维细胞的纤维增殖能力。差异信号的机制及其对纤维化的意义将通过以下特定目的来探讨:1)通过定义调节增殖反应的细胞内信号通路和确定Thy-1表达对信号和增殖的影响,阐明Thy-1成纤维细胞增殖反应增强的分子机制;2)通过比较Thy-1/-基因靶向小鼠和野生型小鼠以及通过骨髓移植恢复Thy-1造血细胞表达的嵌合体Thy-1-/-小鼠的纤维化,表征Thy-1表达在实验诱导的肺纤维化中的后果;3)通过对特发性肺纤维化患者肺移植前后肺成纤维细胞增殖及信号转导的研究,探讨成纤维细胞Thy-1的表达在特发性肺纤维化中的作用。了解成纤维细胞亚群在肺纤维化形成中的作用及其激活机制,可能为针对这一衰弱过程的新型细胞和途径特异性治疗干预提供理论基础。
英文摘要
Fibrotic scarring of the lung causes significant disability, often leading to death. Persistent fibroblast proliferation is resistant to treatment and portends a poor prognosis. The expression of Thy-1 glycoprotein seems to be a key element affecting the fibrotic potential of fibroblasts. Fibroblasts lacking Thy-1 (Thy-1-) share many of the phenotypic features characteristic of fibroblasts from fibrotic lesions and have enhanced proliferative responses to fibrogenic growth factors, which may lead to their accumulation or persistence in fibrotic lesions. The proposed studies are based on the hypothesis that the expression of Thy-1 alters activation of intracellular signaling pathways and cellular responses to fibrogenic mediators, thus modulating the fibroproliferative potential of fibroblasts. The mechanisms for differential signaling and the implications for fibrosis will be explored through the following specific aims: 1) To elucidate the molecular mechanisms for the enhanced proliferative responses observed in Thy-1- fibroblasts, by defining intracellular signaling pathways modulating proliferative responses and by defining the effects of Thy-1 expression on signaling and proliferation; 2) To characterize the consequences of Thy-1 expression in experimentally-induced lung fibrosis, by comparing fibrosis in Thy-1-/- gene-targeted mice to those in wild-type mice, and in chimeric Thy-1-/- mice in which hematopoietic cell expression of Thy-1 has been restored by bone marrow transplantation; and 3) To determine the role of fibroblast Thy-1 expression in idiopathic pulmonary fibrosis, by exploring fibroblast proliferation and signaling in situ and ex vivo in explanted lungs from IPF patients undergoing lung transplantation, compared to those in control tissues. Understanding the roles of subpopulations of fibroblasts in lung fibrogenesis, and the mechanisms of their activation, is likely to provide rationale for novel cell- and pathway-specific therapeutic interventions for this debilitating process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
KULMAP: Human Kidney, urinary tract and lung mapping center
-
批准号:9987373
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2019
-
负责人:James S. Hagood
-
依托单位:
KULMAP: Human Kidney, urinary tract and lung mapping center
-
批准号:10413576
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2018
-
负责人:James S. Hagood
-
依托单位:
Organ Specific Project
-
批准号:10237125
-
项目类别:
-
资助金额:$31.05万
-
财政年份:2018
-
负责人:James S. Hagood
-
依托单位:
KULMAP: Human Kidney, urinary tract and lung mapping center
-
批准号:10237122
-
项目类别:
-
资助金额:$184.85万
-
财政年份:2018
-
负责人:James S. Hagood
-
依托单位:
KULMAP: Human Kidney, urinary tract and lung mapping center
-
批准号:9791201
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2018
-
负责人:James S. Hagood
-
依托单位:
Targeting the Apoptosis-Resistant Pulmonary Myofibroblast
-
批准号:8677065
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2012
-
负责人:James S. Hagood
-
依托单位:
Childhood Interstitial & Diffuse Lung Disease Scientific Conference
-
批准号:8319294
-
项目类别:
-
资助金额:$2.3万
-
财政年份:2012
-
负责人:James S. Hagood
-
依托单位:
Targeting the Apoptosis-Resistant Pulmonary Myofibroblast
-
批准号:8516090
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2012
-
负责人:James S. Hagood
-
依托单位:
Targeting the Apoptosis-Resistant Pulmonary Myofibroblast
-
批准号:8371194
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2012
-
负责人:James S. Hagood
-
依托单位:
Epigenetic Alterations in IPF Fibroblastic Foci
-
批准号:7712750
-
项目类别:
-
资助金额:$7.32万
-
财政年份:2009
-
负责人:James S. Hagood
-
依托单位:
Regulation of Fibroblast Phenotype in Lung Fibrosis
-
批准号:7824718
-
项目类别:
-
资助金额:$1.81万
-
财政年份:2009
-
负责人:James S. Hagood
-
依托单位:
Regulation of Fibroblast Phenotype in Lung Fibrosis
-
批准号:7318994
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2007
-
负责人:James S. Hagood
-
依托单位:
Regulation of Fibroblast Phenotype in Lung Fibrosis
-
批准号:9291496
-
项目类别:
-
资助金额:$33.48万
-
财政年份:2007
-
负责人:James S. Hagood
-
依托单位:
Regulation of Fibroblast Phenotype in Lung Fibrosis
-
批准号:7894813
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2007
-
负责人:James S. Hagood
-
依托单位:
Regulation of Fibroblast Phenotype in Lung Fibrosis
-
批准号:7645802
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2007
-
负责人:James S. Hagood
-
依托单位:
Regulation of Fibroblast Phenotype in Lung Fibrosis
-
批准号:8787052
-
项目类别:
-
资助金额:$42.6万
-
财政年份:2007
-
负责人:James S. Hagood
-
依托单位:
Regulation of Fibroblast Phenotype in Lung Fibrosis
-
批准号:8890859
-
项目类别:
-
资助金额:$54.84万
-
财政年份:2007
-
负责人:James S. Hagood
-
依托单位:
Regulation of Fibroblast Phenotype in Lung Fibrosis
-
批准号:7483042
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2007
-
负责人:James S. Hagood
-
依托单位:
Role of Fibroblast Thy-1 in Pulmonary Fibrosis
-
批准号:6473087
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2002
-
负责人:James S. Hagood
-
依托单位:
Role of Fibroblast Thy-1 in Pulmonary Fibrosis
-
批准号:6613065
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2002
-
负责人:James S. Hagood
-
依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: